Evidence Summary
The effects of cGMP on general health status in children with PKU
This infographic summarises the randomised crossover clinical trial that investigated whether a glycomacropeptide (GMP)-based protein substitute (PS) offers long-term health benefits compared to L-amino acid (L-AA) PS in children with Phenylketonuria (PKU).
The focus areas included GI symptoms, gut health, satiety, inflammation, renal function, oxidative stress, and blood phenylalanine (Phe) control.
09/12/2025
Want to access this resource?
